U.S. News expanded its 2026-2027 hospital rankings with new regional specialty evaluations in cancer and cardiovascular care while increasing recognition for regional hospitals. Rankings continued to emphasize risk-adjusted mortality, preventable complications, patient experience, and objective outcomes measures.

Researchers identified distinct neuronal populations within the heart’s intrinsic nervous system that regulate cardiac rhythm and stress responses in mice. The findings provide mechanistic insight into cardiac neurobiology, though human relevance remains uncertain.

In a single-center cross-sectional study of 75 symptomatic patients, coronary artery calcium score and carotid intima-media thickness were associated with CT-derived CAD severity. The findings support risk-stratification interest but require prospective validation.

The FDA approved Furoscix ReadyFlow, a subcutaneous furosemide autoinjector for edema associated with heart failure or chronic kidney disease. Clinical data demonstrated pharmacokinetic exposure and diuretic effects comparable to intravenous furosemide.

The ACC updated its expert consensus pathway for HFpEF, emphasizing diagnostic scoring, comorbidity assessment, and newer cardiometabolic therapies. The pathway reflects emerging evidence while remaining aligned with existing heart failure guidelines.

Women presenting with acute myocardial infarction often report chest pain alongside additional symptoms such as dyspnea, nausea, fatigue, or jaw pain. Persistent diagnostic disparities continue to contribute to delays in recognition and treatment, particularly among younger women.